Get all the latest on Budget 2026: real‑time headlines, expert analysis, tax changes, sector‑wise expectations and implications for individuals, businesses and the economy on Business Standard ...

Bristol Myers Squibb’s BMY boasts a deep and promising pipeline. Key pipeline candidates with multi-billion-dollar potential ...

CHENNAI: Kerala Governor Rajendra Vishwanath Arlekar, on Thursday, assumed additional charge as Tamil Nadu Governor at the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

A New York City man will likely spend the rest of his life in prison for murdering his lover by stabbing him over 120 times ...

Adding a minimally invasive laser procedure to immunotherapy achieved dramatically improved survival in a small study of ...

Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee, on Friday chaired a meeting of the ...

The market for immunoassays targeting neurological biomarkers is driven by the global rise in neurological disorders, increasing demand for early diagnostics, AI integration enhancing biomarker ...

Merck is upgraded to buy, driven by improving dividend cushion ratio (DCR) and robust FQ4 2025 earnings recovery. Click here to read why MRK and ABBV.

Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Merck & Co., Inc. (NYSE:MRK) with ...

On February 25, RBC Capital initiated coverage of Merck & Co., Inc. (NYSE:MRK) with an Outperform rating and a $142 price target. The firm believes investor interest in the stock could continue, ...

Its Oncology segment comprises around 27% of total revenues and 42% of its Innovative Medicine segment sales. Its oncology sales rose 20.9% on an operational basis in 2025, driven by strong market ...